LMAT
Price
$87.73
Change
-$1.91 (-2.13%)
Updated
Nov 14, 12:39 PM (EDT)
Capitalization
2.03B
97 days until earnings call
Intraday BUY SELL Signals
PDEX
Price
$32.24
Change
+$0.40 (+1.26%)
Updated
Nov 14, 02:04 PM (EDT)
Capitalization
103.44M
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LMAT vs PDEX

Header iconLMAT vs PDEX Comparison
Open Charts LMAT vs PDEXBanner chart's image
LeMaitre Vascular
Price$87.73
Change-$1.91 (-2.13%)
Volume$100
Capitalization2.03B
Pro-Dex
Price$32.24
Change+$0.40 (+1.26%)
Volume$100
Capitalization103.44M
LMAT vs PDEX Comparison Chart in %
LMAT
Daily Signal:
Gain/Loss:
PDEX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LMAT vs. PDEX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a Buy and PDEX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (LMAT: $89.64 vs. PDEX: $31.84)
Brand notoriety: LMAT and PDEX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LMAT: 122% vs. PDEX: 34%
Market capitalization -- LMAT: $2.03B vs. PDEX: $103.44M
LMAT [@Pharmaceuticals: Other] is valued at $2.03B. PDEX’s [@Pharmaceuticals: Other] market capitalization is $103.44M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.47B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LMAT’s FA Score shows that 1 FA rating(s) are green whilePDEX’s FA Score has 0 green FA rating(s).

  • LMAT’s FA Score: 1 green, 4 red.
  • PDEX’s FA Score: 0 green, 5 red.
According to our system of comparison, LMAT is a better buy in the long-term than PDEX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LMAT’s TA Score shows that 5 TA indicator(s) are bullish while PDEX’s TA Score has 5 bullish TA indicator(s).

  • LMAT’s TA Score: 5 bullish, 3 bearish.
  • PDEX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LMAT is a better buy in the short-term than PDEX.

Price Growth

LMAT (@Pharmaceuticals: Other) experienced а +4.72% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.44%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was +7.03%.

Reported Earning Dates

LMAT is expected to report earnings on Feb 19, 2026.

PDEX is expected to report earnings on Jan 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+1.44% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LMAT($2.03B) has a higher market cap than PDEX($103M). LMAT has higher P/E ratio than PDEX: LMAT (38.64) vs PDEX (9.55). LMAT YTD gains are higher at: -2.036 vs. PDEX (-31.893). LMAT has higher annual earnings (EBITDA): 73.8M vs. PDEX (14.1M). LMAT has more cash in the bank: 319M vs. PDEX (7.16M). PDEX has less debt than LMAT: PDEX (16.6M) vs LMAT (186M). LMAT has higher revenues than PDEX: LMAT (235M) vs PDEX (66.6M).
LMATPDEXLMAT / PDEX
Capitalization2.03B103M1,975%
EBITDA73.8M14.1M523%
Gain YTD-2.036-31.8936%
P/E Ratio38.649.55405%
Revenue235M66.6M353%
Total Cash319M7.16M4,456%
Total Debt186M16.6M1,120%
FUNDAMENTALS RATINGS
LMAT vs PDEX: Fundamental Ratings
LMAT
PDEX
OUTLOOK RATING
1..100
918
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
2290
SMR RATING
1..100
5735
PRICE GROWTH RATING
1..100
5661
P/E GROWTH RATING
1..100
8198
SEASONALITY SCORE
1..100
3n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LMAT's Valuation (38) in the Medical Specialties industry is in the same range as PDEX (65) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.

LMAT's Profit vs Risk Rating (22) in the Medical Specialties industry is significantly better than the same rating for PDEX (90) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew significantly faster than PDEX’s over the last 12 months.

PDEX's SMR Rating (35) in the Medical Or Nursing Services industry is in the same range as LMAT (57) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to LMAT’s over the last 12 months.

LMAT's Price Growth Rating (56) in the Medical Specialties industry is in the same range as PDEX (61) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.

LMAT's P/E Growth Rating (81) in the Medical Specialties industry is in the same range as PDEX (98) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LMATPDEX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LMAT
Daily Signal:
Gain/Loss:
PDEX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNRCX43.33N/A
N/A
Fidelity Advisor Energy C
AHSCX12.91-0.20
-1.53%
Alger Health Sciences C
COFYX42.07-0.78
-1.82%
Columbia Contrarian Core Inst3
VPRSX14.25-0.34
-2.33%
VY® JPMorgan Small Cap Core Equity R6
CHCCX13.42-0.55
-3.94%
AB Discovery Growth C

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
-0.37%
ITGR - LMAT
48%
Loosely correlated
-2.10%
SYK - LMAT
46%
Loosely correlated
+1.66%
UFPT - LMAT
44%
Loosely correlated
-1.26%
AORT - LMAT
40%
Loosely correlated
-4.28%
SOLV - LMAT
40%
Loosely correlated
+1.88%
More

PDEX and

Correlation & Price change

A.I.dvisor tells us that PDEX and LMAT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and LMAT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-1.97%
LMAT - PDEX
28%
Poorly correlated
-0.37%
LDXHF - PDEX
25%
Poorly correlated
N/A
TCMD - PDEX
24%
Poorly correlated
-0.89%
PRE - PDEX
23%
Poorly correlated
-2.88%
BDX - PDEX
23%
Poorly correlated
+0.48%
More